Stockreport

BioMarin Pharmaceuticals: Amicus Transforms Business Case Overnight [Seeking Alpha]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF BMRN pays a steep premium—over 8x sales—for Amicus, aiming to diversify growth engines in rare diseases. The deal is expected to be accretive to 2027 earnings, but im [Read more]